Editorial: Benefit and risk on drug-drug interactions in infections
Saved in:
| Main Authors: | Hideo Kato, Nobuhiro Asai, Mao Hagihara |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Microbiology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2025.1600984/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A 15-Year Observational Cohort of Acute Empyema at a Single-Center in Japan
by: Nobuhiro Asai, et al.
Published: (2024-12-01) -
Editorial: Natural remedies repositioned: advancing drug discovery for infectious diseases
by: John Ogbaji Igoli, et al.
Published: (2025-07-01) -
Combination drug therapy as a strategy to improve the efficacy and safety of treatment of herpes simplex virus infections: potential risks and prospects
by: Valeriya L. Andronova, et al.
Published: (2025-07-01) -
Treatment of Onychomycosis and the Drug–Drug Interactions in Patients with Diabetes Mellitus and Diabetic Foot Syndrome: A Systematic Review
by: David Navarro-Pérez, et al.
Published: (2025-01-01) -
Pilot study: Evaluation of potential drug–drug interactions in hospitalized pediatric patients
by: Fabiola Medina-Barajas, et al.
Published: (2020-06-01)